RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 83 filers reported holding RELMADA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $732,603 | -13.4% | 244,201 | -29.0% | 0.00% | – |
Q2 2023 | $846,178 | +185059.3% | 343,975 | +70.0% | 0.00% | – |
Q1 2023 | $457 | -87.7% | 202,328 | -80.9% | 0.00% | -100.0% |
Q4 2022 | $3,706 | -100.0% | 1,061,774 | +362.4% | 0.00% | -60.0% |
Q3 2022 | $8,501,000 | +115.4% | 229,630 | +10.5% | 0.01% | +150.0% |
Q2 2022 | $3,947,000 | -52.8% | 207,810 | -32.9% | 0.00% | -50.0% |
Q1 2022 | $8,356,000 | -38.6% | 309,589 | -48.7% | 0.00% | -42.9% |
Q4 2021 | $13,608,000 | +103.9% | 603,992 | +137.3% | 0.01% | +75.0% |
Q3 2021 | $6,673,000 | +1185.7% | 254,580 | +1468.7% | 0.00% | – |
Q2 2021 | $519,000 | -80.7% | 16,229 | -78.7% | 0.00% | -100.0% |
Q1 2021 | $2,689,000 | -23.7% | 76,369 | -30.5% | 0.00% | -33.3% |
Q4 2020 | $3,526,000 | +63.0% | 109,930 | +91.2% | 0.00% | 0.0% |
Q3 2020 | $2,163,000 | -48.2% | 57,500 | -38.4% | 0.00% | -50.0% |
Q2 2020 | $4,177,000 | +218.6% | 93,328 | +142.9% | 0.01% | +100.0% |
Q1 2020 | $1,311,000 | +44.9% | 38,423 | +65.6% | 0.00% | +200.0% |
Q4 2019 | $905,000 | – | 23,201 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
Savior LLC | 3,500 | $10,500 | 0.07% |
Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |